EVOMMUNE, INC. reports a Return on Equity (ROE) of -24.95%.

What is EVMN's dividend yield?

EVOMMUNE, INC. offers a dividend yield of 0.00%.

What is EVMN's Deepscope Quality Score?

Deepscope rates EVMN's overall financial quality at 31 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy EVMN?

Deepscope's AI Timing Score for EVMN is 27 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does EVMN belong to?

EVOMMUNE, INC. is classified under the Healthcare >> Biotechnology sector on the NYSE exchange.

EVMN (NYSE) 株価分析 | EVOMMUNE, INC.

Stock Check Daily update data at 9:30 AM
(Price: 2026-06-10 | FS: 2026-03-31)

EVMN

EVOMMUNE, INC.

US:NYSE STOCK Healthcare >> Biotechnology News 90

USD 20.49

0.00 (0.00%) Day Change

Watchlist Portfolio Compare Chart

0.01

D/E

-25.0%

ROE

-23.6%

ROA

0.00%

Div Yield

EVOMMUNE, INC.
TYPE: STOCK
MARKET: NYSE

Compare Watchlist Myport

USD 20.49 Price 0.00 (0.00%) Day Change	NEWS SCORE: 90

EVMN, ファンダメンタルスコアはnot good ( ファンダメンタル = 31) そしてテクニカルスコアは ...(Sign In to See)...

Loading chart...

31 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: ROEが低い
ROAが低い
ROEの伸びが低い
平均ROEが低い
昨年度のROEが一昨年比で低い
ROAがROEに比べて低い
ROAの伸びが低い
NPMが低い
NPMの伸びが低い

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Lorem ipsum dolor sit amet

Unlock timing signals and detailed reasons

In details, quality factors are not good , financial health is not good , and ability to make profit is ok , ...

Deepscope 分析

41%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	90
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	20.49
PBV / Sector	2.42 / 4.79
Earning Per Share	-2.11

PE / Sector	N/A / 17.89
PEG or PE/Growth / Sector	N/A / 0.56
Average 1M Daily Value	8.53 M
Average 1W Daily Value	8.60 M

Timing Factors

28%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

45%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

ポイントになる統計

64%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	-759.87 / 468.85
NPM Average (%) / Sector	-731.27 / -1,531.69
NPM Change Average (%) / Sector	13.03 / 5,028.65 GOOD
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-23.57 / 31.69
ROA Average (%) / Sector	-45.86 / -353.18
ROA Change Average (%) / Sector	8.00 / 5,214.65
ROE (%) / Sector	-24.95 / 10.58
ROE Average (%) / Sector	7.92 / 27.64
ROE Change Average (%) / Sector	-64.05 / 2,048.88
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

配当

Dividend (%) / Sector	N/A / 0.05
Dividend Average (%) / Sector	N/A / 16.49
Dividend Change Average (%) / Sector	N/A / 4.77

登録情報

Analyze Date	2026-06-11 09:54:36
Symbol	EVMN
Name	EVOMMUNE, INC.
Sector	Healthcare >> Biotechnology
Market	NYSE
Listed Shares	36.02 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	738.02 / 8,963.32

ニュース

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 1891 Page Mill Road, Palo Alto, CA, United States, 94304

Phone: (925) 247-4481

Website: https://www.evommune.com

Sector: Healthcare >> Biotechnology

Description: Evommune, Inc. operates as a clinical-stage biotechnology company in the United States. The company develops therapies that target key drivers of chronic inflammatory diseases, with initial clinical development programs focusing on chronic spontaneous urticaria, atopic dermatitis, and ulcerative colitis. Its products include EVO756 for the treatment of CSU and AD; and EVO301 for the treatment of AD and UC. The company was incorporated in 2020 and is based in Palo Alto, California.